SPOTLIGHT: Bradley wins FDA OK

Bradley Pharmaceuticals has been notified by MediGene that MediGene received FDA approval to market Polyphenon E Ointment, 15 percent, a new drug indicated for the treatment of external genital and perianal warts. Report

Suggested Articles

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.

The role gives one of the driving forces behind Bristol Myers Squibb’s $74 billion takeover of Celgene the chance to help build biotechs.

The appointment gives Sino-American biotech Brii the experience of a man who helped Gilead launch eight drugs in China in quick succession.